Phase 1Completed
Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection
An Experiment to Evaluate the Drug-drug Interaction of Formula Edaravone and Formula 2-Aminoethanesulfonic Acid in Compound Edaravone Injection
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd. (Industry)
- Enrolment
- 24 enrolled
- Conditions
- Drug-drug Interaction
- Interventions
- Compound Edaravone Injection; Edaravone Injection; 2-Aminoethanesulfonic Acid Injection
- Ages
- adults, older adults
- Registry
- NCT04218513
Full record on ClinicalTrials.gov
From the registry
An experiment to evaluate the drug-drug interaction of formula edaravone and formula 2-aminoethanesulfonic acid in compound edaravone injection.
Primary outcomes
- Cmax of edaravone with and without coIntravenous with 2-Aminoethanesulfonic Acid
- AUC0-t of edaravone with and without coIntravenous with 2-Aminoethanesulfonic Acid
- AUC0-∞ of edaravone with and without coIntravenous with 2-Aminoethanesulfonic Acid
History
Last registry update
Registered
Primary completion
Started